This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

China Cord Blood Corp (CO)

NYSE: Health Care

Company Income Statement
Mar 2015 Mar 2014 Mar 2013 Mar 2012
Sales 102.30M 92.32M 84.66M 60.43M
Cost of Sales 21.04M 10.56M 10.89M 9.10M
Gross Operating Profit 81.26M 81.76M 73.77M 51.33M
Selling, General, and Administrative Expenses 41.82M 36.25M 32.46M 24.04M
Research & Development 1.60M 1.58M 1.36M 1.21M
Operating Income before D & A (EBITDA) 37.85M 43.93M 39.95M 26.08M
Depreciation & Amortization n.a. 6.56M 6.27M 4.66M
Interest Income 2.94M 2.72M 2.42M 2.13M
Other Income - Net 479.02K 369.38K -125.67K -96.25K
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 41.27M 42.06M 36.73M 24.60M
Interest Expense 16.28M 11.29M 11.28M 522.08K
Pre-Tax Income 24.99M 30.77M 25.45M 24.08M
Income Taxes 7.62M 9.41M 6.20M 1.53M
Minority Interest 80.70K 100.40K 1.16M 1.59M
Net Income From Continuing Operations 17.36M 21.36M 19.25M 22.55M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 17.36M 21.36M 19.25M 22.55M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 17.28M 21.26M 18.09M 20.96M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 21.36M 19.25M 22.55M
Preferred Dividends
Net Income Available To Common 0.00 21.36M 19.25M 22.55M
Basic EPS from Continuing Ops. 0.22 0.29 0.25 0.30
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.22 0.29 0.25 0.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.03 -0.01 -0.01
Basic EPS, Total 0.22 0.26 0.24 0.28
Basic Normalized Net Income/Share n.a. 0.29 0.25 0.30
EPS fr Continuing Ops. 0.22 0.29 0.25 0.30
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.22 0.29 0.25 0.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.03 -0.01 -0.01
EPS, Total 0.22 0.26 0.24 0.28
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 0.29 0.25 0.30
Dividends Paid per Share 0.00 0.00 0.00 0.00
CO News

CO China Cord Blood Corp

Chart of CO

Analysts Ratings for CO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 2 2
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CO ANALYST REPORT

Brokerage Partners

CO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs